Acquisitions30 Jul 2025, 05:31 pm
Aurobindo Pharma Subsidiary to Acquire Curateq Biologics s.r.o. for INR 303 Million
AI Summary
Aurobindo Pharma Ltd. has announced that its wholly owned subsidiary, Curateq Biologics B.V., will acquire Curateq Biologics s.r.o., a wholly owned step-down subsidiary of the Company, from Helix Healthcare B.V., another wholly owned subsidiary of the Company. The transaction is valued at EUR 3,000,000 (INR 303 million).
Key Highlights
- Aurobindo Pharma's subsidiary to acquire Curateq Biologics s.r.o.
- Transaction valued at EUR 3,000,000 (INR 303 million)
- Curateq Biologics s.r.o. is a wholly owned step-down subsidiary of the Company
- Acquirer, Curateq Biologics B.V., is a wholly owned subsidiary of the Company
- Target company held by Helix Healthcare B.V., another wholly owned subsidiary of the Company